KEAP1 and hereditary leiomyomatosis and renal cell cancer: Other metabolic derivatives, such as fumarate (Adam et al., 2011; Ooi et al., 2011), have been identified as potential mechanisms underlying the development of HLRCC through the modification of Keap1 via succinylation.